Cargando…

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma

Cripto-1 could promote tumorigenesis in a wide range of carcinomas, yet little is known in hepatocellular carcinoma (HCC). The expression of Cripto-1 and MMP-9 were assessed by immunohistochemistry in 205 HCC specimens. The correlation between Cripto-1 and MMP-9, clinicopathological/prognostic value...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jia-hong, Wei, Wei, Xu, Jing, Guo, Zhi-xing, Xiao, Cheng-zuo, Zhang, Yong-fa, Jian, Pei-en, Wu, Xiao-liang, Shi, Ming, Guo, Rong-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741514/ https://www.ncbi.nlm.nih.gov/pubmed/26375669

Ejemplares similares

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
por: XIAO, CHENG-ZUO, et al.
Publicado: (2015)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
por: Zhang, Yong-Fa, et al.
Publicado: (2016)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome
por: Xue, Yi-Jun, et al.
Publicado: (2019)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2022)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma
por: Liu, Qingqing, et al.
Publicado: (2023)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
por: Zheng, Lin-Lin, et al.
Publicado: (2023)

Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Yi-Wei, et al.
Publicado: (2014)

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
por: Sun, Xiao-Dong, et al.
Publicado: (2016)

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2017)

High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
por: Jin, An‐Li, et al.
Publicado: (2022)

High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Li, Qian, et al.
Publicado: (2021)

Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma
por: Chen, Po-Ming, et al.
Publicado: (2020)

Exploration of the effect of PUM1/Cripto-1 pathway on ferroptosis by regulating macrophage polarization in allogeneic blood transfused mice
por: Wu, Man-Di, et al.
Publicado: (2023)

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection
por: Zhang, Yingyu, et al.
Publicado: (2018)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
por: Wei, Wei, et al.
Publicado: (2018)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma
por: Luo, Rong-Zhen, et al.
Publicado: (2014)

CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis
por: Jin, An‐Li, et al.
Publicado: (2022)

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma
por: Li, Mei, et al.
Publicado: (2011)

Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma
por: Feng, Ying, et al.
Publicado: (2018)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2mon95jme3b67ktuja6k957od9